TrialEuropean heart journal2025

High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial.

Manan Pareek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.